Company

Structure Therapeutics

Biotechnology Research Cn 175 employees

Employees: 175
Contacts: 2
Emails: 2

structuretx.com LinkedIn Crunchbase

Structure Therapeutics Overview

Headquarters: Cn
Website: structuretx.com
Industry: Biotechnology Research
Employees: 175
Founded: 2017
Funding: 547.4M
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

Metabolic Diseases Cardiovascular Diseases Pulmonary Diabetes Computational Chemistry Obesity

About Structure Therapeutics

Structure Therapeutics is a science-driven clinical-stage biopharmaceutical company focused on discovering and developing innovative oral small molecule treatments for chronic metabolic and cardiopulmonary conditions with significant unmet medical needs. Utilizing its next generation structure-based drug discovery platform, Structure Therapeutics has established a robust GPCR-targeted pipeline, featuring multiple wholly-owned proprietary clinical-stage small molecule compounds designed to surpass the scalability limitations of traditional biologic and peptide therapies and be accessible to more patients around the world.

Structure Therapeutics Contact Details

People in AeroLeads: 4
With contact data: 2
Email contacts: 2; 50.0% coverage

Structure Therapeutics Org Chart

Sample employees and titles

Name	Title	Location	Contact
En You Thong		United States	Email
Eric Dobmeier			View
Peter Slasor		San Francisco, California, United States	Email
Chris De Graaf	VP, Head of Computational Drug		View